New class of drug gives hope to some ovarian cancer patients

Focal brain lesion study shows cognitive impairment may be better predicted by looking at damage to white matter
4 May 2021
Researchers advance 3D printing to aid tissue replacement
4 May 2021

New class of drug gives hope to some ovarian cancer patients

A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build up a resistance to chemotherapy.

Comments are closed.